Keyphrases
Pediatric
100%
T-lymphoblastic Lymphoma
52%
Lymphoblastic Lymphoma
38%
B-cell Precursors
38%
Constitutional Mismatch Repair Deficiency (CMMRD)
33%
Mutational Landscape
33%
Transcriptional Landscape
33%
Lymphoblastic Malignancies
19%
Extramedullary
19%
Lymphoma Patients
19%
Diagnostic Work-up
16%
Positron Emission Tomography-computed Tomography (PET-CT)
16%
Precursor B-cell Lymphoblastic Lymphoma
16%
Notch1
16%
Diagnostic Biomarker
16%
Chemokine Ligands
16%
High Prevalence
16%
Medullary Involvement
16%
F-fluorodeoxyglucose Positron Emission Tomography
16%
18F-fluorodeoxyglucose (18F-FDG)
16%
Precursor B-cell
16%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
16%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
16%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
16%
Mutational Patterns
16%
Tumor
16%
Mutagenic Processes
16%
B-cell Precursor ALL
15%
Mismatch Repair Genes
9%
Lymphoblastic Leukemia
8%
Hematological Malignancies
7%
T-lymphoblastic
7%
Clinical Characteristics
6%
Leukemia Patients
6%
Cancer Predisposition Syndrome
6%
Formalin-fixed Paraffin-embedded Tissue
6%
Molecular Study
6%
Gene Fusion
5%
Notch Gene
5%
High Risk
5%
B-cell Malignancies
5%
Medicine and Dentistry
Lymphoblastic Lymphoma
54%
Pediatrics
50%
Precursor
36%
T Cell
35%
B Cell
33%
Disease
25%
Cancer
18%
Positron Emission Tomography-Computed Tomography
16%
Chemokine
16%
Thymus and Activation Regulated Chemokine
16%
Biological Marker
16%
Fluorodeoxyglucose
16%
Fluorine-18
16%
Acute B-Cell Lymphoblastic Leukemia
16%
Lymphoid Leukemia
16%
Neoplasm
16%
DNA Mismatch Repair
16%
Tumor
12%
Hematologic Malignancy
7%
Gene Repair
6%
Gene Fusion
5%
Biochemistry, Genetics and Molecular Biology
Precursor
36%
B Cell
33%
T Cell
18%
DNA Mismatch Repair
16%
Deficiency
16%
Gene Repair
6%
